[HTML][HTML] Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2021 - frontiersin.org
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
E Colomier, J Algera, C Melchior - … Treatments Affecting Gastro …, 2022 - books.google.com
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
[PDF][PDF] Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front. Pharmacol. 11: 629026. doi: 10.3389/fphar …
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology …, 2021 - lirias.kuleuven.be
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
[引用][C] Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2021 - hal.science
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With
Diarrhea - Archive ouverte HAL Accéder directement au contenu Documentation FR Français …
Diarrhea - Archive ouverte HAL Accéder directement au contenu Documentation FR Français …
[PDF][PDF] Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front. Pharmacol. 11: 629026. doi: 10.3389/fphar …
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology …, 2021 - researchgate.net
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea.
E Colomier, J Algera, C Melchior - 2021 - cabidigitallibrary.org
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
[HTML][HTML] Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2020 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
E Colomier, J Algera… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2020 - europepmc.org
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2021 - europepmc.org
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …